Menicon Overview
- Founded
-
1951

- Status
-
Public
- Employees
-
4,435

- Stock Symbol
-
7780

- Investments
-
15
- Share Price
-
$20.88
- (As of Friday Closing)
Menicon General Information
Description
Menicon Co Ltd is a contact lens manufacturing company. It is involved in manufacturing, sales, export, and import of contact lenses and other medical goods, manufacturing and sales of medical instruments, sales of medical supplies and research and development of intraocular lenses. The firm's products include soft lenses, gas permeable lenses and lens care products.
Contact Information
- 3-21-19, Aoi
- Naka-ku
- Nagoya, 460-0006
- Japan
Menicon Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$20.88 | $21.00 | $15.24 - $26.80 | $1.58B | 75.9M | 272K | $0.80 |
Menicon Financials Summary
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
---|---|---|---|---|
EV | 1,672,398 | 1,872,978 | 2,244,418 | 1,632,874 |
Revenue | 821,270 | 891,660 | 812,989 | 777,311 |
EBITDA | 155,826 | 137,741 | 109,167 | |
Net Income | 60,730 | 57,689 | 56,130 | 37,339 |
Total Assets | 1,147,887 | 1,073,168 | 1,152,629 | 807,657 |
Total Debt | 415,268 | 347,691 | 410,676 | 124,249 |
Menicon Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Menicon Comparisons
Industry
Financing
Details
Menicon Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Essilor | Corporation | Charenton-le-Pont, France | 000000 | 000000000 | ||
000000 + 0000 | Formerly PE-Backed | Bridgewater, NJ | 00000 | 00000 | 00000000 | 00000 |
Menicon Patents
Menicon Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2022163326-A | Pet protection system | Pending | 14-Apr-2021 | ||
JP-2022119363-A | Algicide and algae removal method | Pending | 04-Feb-2021 | 0000000000 | |
JP-2022066908-A | Storage case for soft contact lens | Pending | 19-Oct-2020 | ||
JP-2022046018-A | Soft contact lens storage case | Pending | 10-Sep-2020 | ||
JP-2021073993-A | Canine cataract testing method, canine cataract testing reagent, and canine cataract testing kit | Pending | 08-Nov-2019 |
Menicon Executive Team (4)
Menicon Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Kyoichi Tanaka | Menicon | Founder & Chairman | 000 0000 |
Ryutaro Honda | Menicon | Board Member | 000 0000 |
Yoshimi Horinishi | Menicon | Board Member | 000 0000 |
Yozo Miyake | Menicon | Board Member | 000 0000 |
Menicon Signals
Menicon Investments & Acquisitions (15)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 0000 | 08-Jan-2021 | 0000000000 | 00000 | Food Products | |
00000000 0000 | 08-Jan-2021 | 000000000 | Food Products | ||
000000 000000 | 02-Oct-2020 | 0000000000 | Distributors/Wholesale | ||
0000000 00000 | 23-Jun-2020 | 0000000000 | Therapeutic Devices | 00000000 | |
Soleko | 02-Oct-2019 | Merger/Acquisition | Medical Supplies |
Menicon Subsidiaries (9)
Company Name | Industry | Location | Founded |
---|---|---|---|
Wenzhou FocuSee Vision Care Technologies | Therapeutic Devices | Wenzhou, China | 2003 |
00000000 0000000 | Food Products | Tokyo, Japan | 0000 |
00000 0000000 | Accessories | Nagoya, Japan | 0000 |
0.0. 000000 000000 | Specialty Retail | Tokyo, Japan | 0000 |
0000 0 00000000000 | Therapeutic Devices | Hamilton, New Zealand | 0000 |
Menicon ESG
Risk Overview
Risk Rating
Updated February, 09, 2023
14.5 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,231
Rank
Percentile

Healthcare
Industry
00 of 601
Rank
Percentile

Medical Supplies
Subindustry
0. of 57
Rank
Percentile
